Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 322

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 322
---
 NorthView’s stockholders and approval by Nasdaq of the initial listing application in connection with the Merger. • Potential litigation.The possibility of litigation challenging the Merger or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin consummation of the Merger. • Fees and expenses.The fees and expenses associated with completing the Merger. • Potential impacts of COVID -19 .Uncertainties regarding the potential impacts of the COVID -19virus and related economic disruptions on Profusa’s operations. • Other risk factors.Various other risk factors associated with the respective businesses of NorthView and Profusa as described in the section entitled “ Risk Factors” appearing elsewhere in this proxy statement/prospectus. We may complete the Business Combination only if it is approved by the affirmative vote of the members representing at least a simple majority of the votes cast by holders of NorthView Common Stock present and voting in person or by proxy at the special meeting of NorthView stockholders. The Business Combination is therefore not structured so that approval of at least a majority of unaffiliated NorthView Stockholders is required. No unaffiliated representative has been retained to act solely on behalf of the NorthView stockholders for purposes of negotiating the terms of the Merger Agreement on their behalf and/or preparing a report concerning the approval of the Business Combination. The Business Combination was unanimously approved by NorthView’s Board. The NorthView Board concluded that the potential benefits expected for NorthView and its stockholders as a result of the Merger outweighed the any potentially negative factors related to the Merger. Accordingly, the NorthView Board unanimously determined that the Merger Agreement, and the transactions contemplated thereby, including the Merger, were advisable, fair to and in the best interests of NorthView and its stockholders. 162 Profusa Reasons for the Merger In the course of reaching its decision to approve the merger, the Profusa board of directors held numerous meetings, consulted with Profusa’s senior management, its financial advisors and legal counsel, and considered a wide variety of factors including, among others, the following material factors (which factors are not necessarily presented in any order of relative importance): •the merger will provide Profusa’s current stockholders with greater liquidity by owning publicly -tradedstock, and expanding both the access to capital for Profusa and the range of investors potentially available as a public company, compared to the investors Profusa could otherwise gain access to if it continued to operate as a privately -heldcompany; •the potential benefits from increased public market awareness